HUP9904171A2 - A ragadós száj- és körömfájás vírusok immunogén peptidjei - Google Patents

A ragadós száj- és körömfájás vírusok immunogén peptidjei

Info

Publication number
HUP9904171A2
HUP9904171A2 HU9904171A HUP9904171A HUP9904171A2 HU P9904171 A2 HUP9904171 A2 HU P9904171A2 HU 9904171 A HU9904171 A HU 9904171A HU P9904171 A HUP9904171 A HU P9904171A HU P9904171 A2 HUP9904171 A2 HU P9904171A2
Authority
HU
Hungary
Prior art keywords
rszkfv
vaccines
peptides
foot
mouth disease
Prior art date
Application number
HU9904171A
Other languages
English (en)
Inventor
Roberto Correa
Bernadette Glatthaar-Saalmüller
Hans-Robert Hehnen
Bettina Höhlich
Thomas Pauly
Eberhard Pfaff
Armin Saalmüller
Karl-Heinz Wiesmüller
Original Assignee
Bayer Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag. filed Critical Bayer Ag.
Publication of HUP9904171A2 publication Critical patent/HUP9904171A2/hu
Publication of HUP9904171A3 publication Critical patent/HUP9904171A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány tárgyát RSZKFV-vakcinák (ragadós száj és körömfájás)képezik, amelyek legalább 8 aminősavat tartalmazó, az RSZKFV - RSZKFV-specifikűs ellenanyagőkkal vagy RSZKFV-specifikűs T-lymphőcytákkalszembeni imműnőreaktivitás alapján kiválasztőtt - nem strűktűrálisprőteinrégiója részleges szekvenciájának megfelelő peptidekenalapűlnak. A találmány tárgyát képezik a peptidek is, amelyeken avakcinák alapűlnak. A találmány tárgyát képezik tővábbá eljárásők avakcinák előállítására és a vakcinák és a peptidek alkalmazásai többekközött imműnizálására és száj és RSZKFV-vel fertőzött állatőkkiműtatására, illetve vakcinázőtt és fertőzött állatők közöttikülönbségtételre. A találmány szerinti megőldás RSZKF megelőzése és abetegség vírűsával való fertőzöttség kiműtatása területénalkalmazható. ŕ
HU9904171A 1996-09-18 1997-09-08 Immunogenic peptides of foot-and-mouth disease viruses HUP9904171A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19638044A DE19638044A1 (de) 1996-09-18 1996-09-18 Immunogene Peptide von Maul- und Klauenseuchen-Viren

Publications (2)

Publication Number Publication Date
HUP9904171A2 true HUP9904171A2 (hu) 2000-04-28
HUP9904171A3 HUP9904171A3 (en) 2001-10-29

Family

ID=7806008

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904171A HUP9904171A3 (en) 1996-09-18 1997-09-08 Immunogenic peptides of foot-and-mouth disease viruses

Country Status (14)

Country Link
US (2) US6984387B1 (hu)
EP (1) EP0927256A1 (hu)
CN (1) CN1122108C (hu)
AR (1) AR009365A1 (hu)
AU (1) AU723901B2 (hu)
BR (1) BR9712067A (hu)
CA (1) CA2265518A1 (hu)
DE (1) DE19638044A1 (hu)
HK (1) HK1024262A1 (hu)
HU (1) HUP9904171A3 (hu)
IL (1) IL128847A0 (hu)
RU (1) RU2202613C2 (hu)
WO (1) WO1998012333A1 (hu)
ZA (1) ZA978351B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810888B1 (fr) * 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
JP2009525276A (ja) 2006-01-30 2009-07-09 グロボアジア エルエルシー 慢性腎疾患の治療法
US7715679B2 (en) 2007-05-07 2010-05-11 Adc Telecommunications, Inc. Fiber optic enclosure with external cable spool
US8722079B2 (en) * 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
RU2453557C1 (ru) * 2010-11-03 2012-06-20 Алексей Сергеевич Фолимонов Состав полиэпитопного белка для индукции иммунного ответа против вируса ящура
RU2467014C2 (ru) * 2010-12-06 2012-11-20 Учреждение Российской академии наук Центр "Боинженерия" РАН Полиэпитопный белок, нуклеотидная последовательность, кодирующая полиэпитопный белок, плазмида с последовательностью, кодирующей полиэпитопный белок, и препарат полиэпитопного белка для индукции иммунного ответа против вируса ящура
CN102998460B (zh) * 2012-10-31 2014-12-10 广东海大畜牧兽医研究院有限公司 一种口蹄疫病毒抗体的elisa试剂盒及其制备方法
CN107513101B (zh) * 2017-09-18 2021-04-13 中牧实业股份有限公司 猪口蹄疫病毒非结构蛋白抗体酶联免疫检测试剂盒
CN111744000B (zh) * 2020-07-14 2021-03-23 中国农业科学院兰州兽医研究所 免疫抑制功能降低的口蹄疫重组病毒及其制备方法与应用
CN117304277B (zh) * 2023-09-26 2024-03-08 中国农业科学院兰州兽医研究所 一种o型口蹄疫病毒vp4蛋白t细胞表位多肽及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140763A (en) * 1976-09-08 1979-02-20 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for foot and mouth disease
ZA831854B (en) * 1982-03-26 1984-01-25 Biogen Nv Small peptides with the specificity of foot and mouth disease viral antigens
WO1983003547A1 (en) * 1982-04-14 1983-10-27 Bittle, James, L. Synthetic picornavirus antigen
US4732971A (en) * 1985-06-03 1988-03-22 Eli Lilly And Company Synthetic vaccines for foot and mouth disease
JPH03503416A (ja) * 1988-03-25 1991-08-01 マリンクロットベタリナリィ，インコーポレイテッド ペプチド
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
JP2813768B2 (ja) * 1995-05-24 1998-10-22 農林水産省家畜衛生試験場長 口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
US6048538A (en) 1997-10-03 2000-04-11 United Biomedical, Inc. Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents

Also Published As

Publication number Publication date
DE19638044A1 (de) 1998-03-19
ZA978351B (en) 1998-03-24
RU2202613C2 (ru) 2003-04-20
AU723901B2 (en) 2000-09-07
WO1998012333A1 (de) 1998-03-26
HK1024262A1 (en) 2000-10-05
AU4553697A (en) 1998-04-14
CN1122108C (zh) 2003-09-24
EP0927256A1 (de) 1999-07-07
BR9712067A (pt) 1999-08-24
CN1238011A (zh) 1999-12-08
HUP9904171A3 (en) 2001-10-29
US6984387B1 (en) 2006-01-10
US20050058656A1 (en) 2005-03-17
AR009365A1 (es) 2000-04-12
CA2265518A1 (en) 1998-03-26
IL128847A0 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
FR07C0073I2 (fr) Vaccin contre le papillomavirus
HUP9904171A2 (hu) A ragadós száj- és körömfájás vírusok immunogén peptidjei
HK1053662A1 (en) Gag antigen and its use for the detection of lav infection and in immunogenic compositions
RU98101249A (ru) Омр26 антиген haemophylus influenzae
CY1106152T1 (el) Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
DK0815235T3 (da) Vacciner mod pest
EA200000596A1 (ru) Tat вич-1 или его производные для профилактической и лечебной вакцинации
CY1105010T1 (el) Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου
DK2011510T3 (da) Farmaceutiske sammensætninger indeholdende immunologisk aktive Herpes simplex-virus(HSV) proteinfragmenter
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
FR2670787B1 (fr) Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.
HK141594A (en) Peptide fragments of HIV and their use in vaccines and diagnosis
HUP9801334A2 (hu) A 18-as típusú humán papillomavírust kódoló DNS
RU99108121A (ru) Иммуногенные пептиды вирусов ящура
GB2250994B (en) Peptide fragments of hiv
HUP0102730A2 (hu) Neisseria meningitidis antigén tulajdonságú polipeptidek, megfelelő polinuklotidok és védelmet nyújtó ellenanyagok
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
HUP0102235A1 (hu) Moraxella catarrhalis BASBO27-fehérjék és -gének, továbbá antigének, ellenanyagok és alkalmazások
ES2105984A1 (es) Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
RU98105627A (ru) Вакцины
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
TH105711B (th) การสร้างภูมิคุ้มกันของปลาด้วยโปรตีนสายผสม(recombinant protein)ที่แสดงออกในพืช

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees